SV40 Pseudovirion gene delivery of a toxin to treat human adenocarcinomas in mice
Open Access
- 24 February 2006
- journal article
- research article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 13 (7) , 648-657
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Hodgkin lymphoma therapy with interleukin-4 receptor–directed cytotoxin in an infiltrating animal modelBlood, 2005
- Studies of Targeting and Intracellular Trafficking of an Anti-Androgen Doxorubicin−Formaldehyde Conjugate in PC-3 Prostate Cancer Cells Bearing Androgen Receptor-GFP ChimeraJournal of Medicinal Chemistry, 2004
- Analysis of Antitumor Activity of an Interleukin-13 (IL-13) Receptor-Targeted Cytotoxin Composed of IL-13 Antagonist and Pseudomonas ExotoxinClinical Cancer Research, 2004
- Interleukin-4 receptor cytotoxin as therapy for human malignant pleural mesothelioma xenograftsThe Annals of Thoracic Surgery, 2004
- Use of suicide genes for cancer gene therapy: study of the different approachesExpert Opinion on Biological Therapy, 2004
- Retroviral Immunotoxin Gene Therapy of Leukemia in Mice Using Leukemia-Specific T Cells Transduced with an Interleukin-3/Bax Fusion Protein GeneHuman Gene Therapy, 2003
- High Cloning Capacity of In Vitro Packaged SV40 Vectors with No SV40 Virus SequencesHuman Gene Therapy, 2003
- A bivalent disulfide-stabilized fv with improved antigen binding to erbb2Journal of Molecular Biology, 1998
- Gene Transfer of Drug Resistance Genes Implications for Cancer TherapyAnnals of the New York Academy of Sciences, 1994
- Pseudomonas Exotoxin and Recombinant Immunotoxins Derived from ItAnnals of the New York Academy of Sciences, 1993